Regenerative Medicine Market: Current Analysis and Forecast (2024-2032)

Report Description

Regenerative Medicine Market Size & Forecast

The Regenerative Medicine market was valued at approximately USD 16.5 billion in 2023 and is expected to grow at a substantial CAGR of around 20% during the forecast period (2024-2032) owing to the Rising cases of chronic diseases, including diabetes and cardiovascular conditions.

Regenerative Medicine Market Analysis

Regenerative medicine is a field of medical science that deals with the treatment of diseases by the healing of damaged tissues and organs. This falls within the realm of regenerative medicine encompassing stem cell therapy, tissue engineering, and gene editing biologics. This encompasses the restoration of tissues and organs that have been affected by injury disease or ailment among others with the potential of creating cures for diseases that were earlier considered incurable.

For instance, with the increasing rates of chronic diseases like diabetes and other heart-related diseases, there is an increased need for regenerative therapies that can repair or regrow tissues. In addition to this, there are increasing advancements in stem cells gene therapy, and tissue engineering that are putting a heightened pace in the development of next-generation regenerative therapies. In addition, healthcare spending enhances the funding of progressive regenerative medicine technology. These collaborations are enabling additional research between both the pharmaceutical and biotechnology firms and research institutions, which has helped in enhancing innovation and shortening the development cycle. For instance, in 2021, The New York Stem Cell Foundation (NYSCF) announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD). They will first target dry AMD, a disease that results from the death of a type of eye cell called retinal pigmented epithelial (RPE) cells and causes vision loss.

Regenerative Medicine Market Trends

This section discusses the key market trends influencing the various segments of the Regenerative Medicine market as identified by our research experts.

Gene Therapy Segment Transforms Regenerative Medicine Industry

Gene therapy forms the regenerative medicine market’s foundation as it provides groundbreaking solutions that attack genetic diseases’ sources. Through the processes of gene addition, gene deletion, or gene modification of specific genes in a patient’s body, gene therapy works to rectify faulty genes that cause diseases. It also makes it possible to treat diseases that were previously deemed to have no cure, thus increasing market demand for new therapies. Technological improvements in gene editing technologies that are currently being used, such as CRISPR, have enhanced research and development in gene therapies and made gene therapies more available. Higher spending and favorable policies and legislation also continue to spur markets’ advances. Also, actual cases of gene therapy increase investors’ confidence and encourage further research and development of gene therapies.

North America leads the market.

North America holds a significant share of the regenerative medicine market through advanced healthcare facilities as well as research institutes. Interest in biotechnology as well as regeneration sciences increases investment and unearths new opportunities. Permissive environments in terms of enhanced regulatory policies such as the FDA fast-track for such drugs make it possible for new therapies to be brought to the market. In December 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy. Due to the increased incidence of chronic diseases and the growing population of the middle-aged and elderly, the region’s demand for regenerative solutions is growing. It has been found with the cooperation of the premier academic institutions and the related biotechnology firms the progression of these is hastened. Moreover, current funding for further research comes from venture capital and government grants at a considerable level. In general, a well-developed market and investment in North America boosts the development of regenerative medicine.

Regenerative Medicine Industry Overview

The Regenerative Medicine market is competitive, with several global and international players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are Organogenesis Inc., Metcela Inc., Arcellx, Mesoblast Ltd, Athersys, Inc., Vericel, Globus Medical, Corline Biomedical AB, U.S. Stem Cell, Inc., Integra LifeSciences Corporation.

Regenerative Medicine Market News

• In May 2024, Taysha Gene Therapies, Inc., a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system (CNS), announced the United States Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to TSHA-102, a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
• In June 2024 – Cryoport, Inc. (“Cryoport”), a global leader in supply chain solutions for the life sciences, and Minaris Regenerative Medicine Co., Ltd. (“Minaris”), a global contract development and manufacturing organization for cell and gene therapies, announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.

Regenerative Medicine Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global Regenerative Medicine market can be customized further as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Frequently Asked Questions (FAQ)

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Regenerative Medicine Market Analysis (2022-2032)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global Regenerative Medicine market were the three major steps undertaken to create and analyze the adoption of Regenerative Medicine in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Regenerative Medicine market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

A detailed secondary study was conducted to obtain the historical market size of the Regenerative Medicine market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Regenerative Medicine market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product, material type, application, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Regenerative Medicine market. Further, we conducted factor analysis using dependent and independent variables such as product, material type, application, and regions of the Regenerative Medicine market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Regenerative Medicine market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Regenerative Medicine market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the Regenerative Medicine market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global Regenerative Medicine market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Regenerative Medicine market. Data was split into several segments and sub-segments after studying various parameters and trends in the product, material type, application, and regions of the global Regenerative Medicine market.

The main objective of the Global Regenerative Medicine Market Study

The current & future market trends of the global Regenerative Medicine market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the Regenerative Medicine market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments.
• Segments in the study include areas of the product, material type, application, and regions.
• Define and analyze the regulatory framework for the Regenerative Medicine
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
• Analyze the current and forecast market size of the Regenerative Medicine market for the major region.
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the Regenerative Medicine market and the growth strategies adopted by the market players to sustain the fast-growing market.
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team